Djordjevic Jelena, Ignjatovic Vesna, Vukomanovic Vladimir, Vuleta Katarina, Ilic Nevenka, Slovic Zivana, Stanojevic Pirkovic Marijana, Mihaljevic Olgica
Department of Pathophysiology, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia.
Department of Nuclear Medicine, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia.
Biomedicines. 2024 Mar 13;12(3):636. doi: 10.3390/biomedicines12030636.
Bearing in mind that coronavirus disease (COVID-19) is associated with a wide range of laboratory abnormalities, the aim of this study was to examine the importance of determining the parameters of oxidative stress and antioxidant protection as well as markers of inflammation and hemostasis in hospitalized patients with COVID-19. The study population included 105 patients with severe COVID-19 and 65 healthy control subjects. The parameters of oxidative stress and the activity of enzymes of the antioxidant system were determined from the obtained samples using spectrophotometric methods. Standard laboratory methods were performed for the determination of the biochemical and hematological parameters. Patients with COVID-19 showed a significantly higher level of pro-oxidative parameters (hydrogen peroxide (HO) and the index of lipid peroxidation in the form of thiobarbituric acid-reactive substances (TBARSs)) and a significantly lower activity of the antioxidant system (catalase (CAT)). Patients with COVID-19 had significantly higher values of inflammation parameters (C-reactive protein (CRP), procalcitonin (PCT), ratio of the number of neutrophils to lymphocytes (NLR), and ratio of the number of platelets to lymphocytes (PLR)) and parameters of hemostasis (activated partial thromboplastin time (aPTT), prothrombin time (PT), D-dimer, fibrinogen) than the control healthy subjects. In addition, changes in hemostatic parameters correlated positively with inflammatory markers in the group of patients with COVID-19. The early determination of hemostasis parameters and the parameters of inflammation can help in the prediction of poor prognosis in COVID-19 patients.
鉴于冠状病毒病(COVID-19)与多种实验室异常情况相关,本研究的目的是检验在住院的COVID-19患者中测定氧化应激参数、抗氧化保护参数以及炎症和止血标志物的重要性。研究人群包括105例重症COVID-19患者和65名健康对照者。使用分光光度法从获得的样本中测定氧化应激参数和抗氧化系统酶的活性。采用标准实验室方法测定生化和血液学参数。COVID-19患者的促氧化参数(过氧化氢(HO)和以硫代巴比妥酸反应性物质(TBARSs)形式存在的脂质过氧化指数)水平显著更高,而抗氧化系统(过氧化氢酶(CAT))的活性显著更低。与健康对照者相比,COVID-19患者的炎症参数(C反应蛋白(CRP)、降钙素原(PCT)、中性粒细胞与淋巴细胞数量之比(NLR)以及血小板与淋巴细胞数量之比(PLR))和止血参数(活化部分凝血活酶时间(aPTT)、凝血酶原时间(PT)、D-二聚体、纤维蛋白原)值显著更高。此外,在COVID-19患者组中,止血参数的变化与炎症标志物呈正相关。早期测定止血参数和炎症参数有助于预测COVID-19患者的不良预后。